Vulvovaginal (vv) graft-versus-host disease (GVHD) is a serious complication of allogenic hematopoietic stem cell transplant (HSCT) that results in vulvar irritation, vaginal stenosis (VS), and menstrual outflow obstruction (MOO). The incidence of vvGVHD post-HSCT is as high as 49%, 2 years post-HSCT in adult women; however, data on the pediatric population is lacking. We aimed to identify the prevalence of vvGVHD, the surveillance of potential genital complications, and the referral of pediatric patients post-HSCT to pediatric and adolescent gynecology (PAG).
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of Pediatric and Adolescent Gynecology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect